Table 1.
Demographic Features of Initial Cohort
| Demographics | Sarcoidosis | Control Patients |
Total | |||
|---|---|---|---|---|---|---|
| ILDa | Eye | OLD | Othera | |||
| No. | 450 (75.0) | 61 (10.2) | 16 (2.7) | 45 (7.5) | 28 (4.7) | 600 |
| Age at diagnosis, mean ± SD, yb | 45 ± 11.4 | 67.07 ± 10.77 | 46 ± 14.6 | 64 ± 16.6 | 67 ± 12.3 | 49 ± 14.9 |
| Blackb | 198 (44.0) | 5 (8.2) | 10 (62.5) | 8 (17.8) | 1 (3.6) | 222 (37.0) |
| White | 251 (55.8) | 50 (82.0) | 6 (37.5) | 35 (77.8) | 27 (96.4) | 369 (61.5) |
| Asian | 1 (0.2) | 4 (6.6) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 5 (0.83) |
| Race not recorded | 0 (0.0) | 2 (3.3) | 0 (0.0) | 2 (4.4) | 0 (0.0) | 4 (0.67) |
| Women | 292 (64.9) | 31 (50.8) | 12 (75.0) | 31 (68.9) | 13 (46.4) | 379 (63.2) |
| Patients with ≥ 1 possible criterion | 450 (100.0) | 56 (91.8) | 16 (100.0) | 43 (95.6) | 20 (71.4) | 585 (97.5) |
Data are presented as No. (%) unless otherwise indicated. ILD = interstitial lung disease; OLD = obstructive lung disease.
a
Eye: ocular disease; other: bronchiectasis, pulmonary nodules, pneumonia, connective tissue disease, malignancy, pleural effusions, vasculitis, and unexplained dyspnea.
b
Difference between groups, P < .00001.